Voyager Therapeutics, Inc. (VYGR) has a market capitalization of $236.19M and trades at $3.96. The 52-week range is 2.65-5.55.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.9, Earnings Per Share (EPS) of $-2.04, annual revenue of $40.37M.
The stock has a beta of 1.38, operates in the Healthcare sector.
